Companies

Indaptus Therapeutics, Inc. (INDP) SEC filings

CIK 0001857044 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Net income (USD)-14.3 M-7.7 M
Diluted EPS (USD/shares)-21.58-1.83-1.73

Latest filings

FiledFormDescriptionPeriod
2026-10-05S-8S-8
2026-09-308-K8-K items 1.01,9.012026-09-29
2026-09-108-K8-K items 1.01,3.02,9.012026-09-08
2026-09-088-K/A8-K/A items 1.01,9.012026-08-28
2026-09-048-K8-K items 5.02,9.012026-09-02
2026-09-04424B5424B5
2026-09-018-K8-K items 1.01,9.012026-08-28
2026-08-31424B5424B5
2026-08-26424B3424B3
2026-08-25EFFECTEFFECT items ,,
2026-08-17S-3S-3
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.02,5.07,9.012026-08-10
2026-07-17EFFECTEFFECT items ,,
2026-07-16DEF 14ADEF 14A2026-07-16
2026-06-26SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-26SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-26SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-26SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-26S-3S-3
2026-06-248-K8-K items 1.01,3.02,9.012026-06-17
2026-06-22PRE 14APRE 14A2026-06-22
2026-06-058-K8-K items 5.02,9.012026-06-01
2026-05-1510-Q10-Q2026-03-31
2026-05-158-K8-K items 2.02,9.012026-05-15

Forms on file (last 1,000): 4 84, 8-K 73, 3 24, 10-Q 17, EFFECT 15, CORRESP 10, UPLOAD 10, 424B5 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=INDP (0.002 USD), /gw/filings/filings?ticker=INDP&form=8-K, /gw/filings/facts?ticker=INDP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange